Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Release
  • Investors
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Our Culture
  • Press shift tab to select search category

    Loading...
  • Global Australia
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Foundation Ipsen
  • Science
      < Back
    • Science
    • Therapeutic Areas
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients
  1. Home
  2. Company
  3. Leadership
  4. Christina Xinos

Christina Xinos

Post navigation

Previous
Next
Christina Xinos

Christina Xinos

  • Medical Director
  • Follow in LinkedIn

Christina is a dynamic leader with over 20 years of medical affairs experience in strategic planning, operations, and field medical excellence. As Country Medical Director since 2023, Christina has been pivotal in shaping and executing the medical affairs strategy and overseeing pharmacovigilance as the Qualified Person for Pharmacovigilance. Passionate about developing high-performing teams, Christina fosters a culture of collaboration to achieve both patient and business outcomes.

IPN price

€116.80

 €-1.40 (-1.18%)

  • Media
  • Investors
  • Careers
  • Annual Report
  • Contact us
  • Distribution

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?

Continue